Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C10H11F3N2O5 |
Molecular Weight | 296.1999 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(C(=O)NC2=O)C(F)(F)F
InChI
InChIKey=VSQQQLOSPVPRAZ-RRKCRQDMSA-N
InChI=1S/C10H11F3N2O5/c11-10(12,13)4-2-15(9(19)14-8(4)18)7-1-5(17)6(3-16)20-7/h2,5-7,16-17H,1,3H2,(H,14,18,19)/t5-,6+,7+/m0/s1
Molecular Formula | C10H11F3N2O5 |
Molecular Weight | 296.1999 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:28:08 UTC 2023
by
admin
on
Sat Dec 16 16:28:08 UTC 2023
|
Record UNII |
RMW9V5RW38
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000175595
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
||
|
NDF-RT |
N0000175459
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
||
|
NDF-RT |
N0000175459
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
||
|
WHO-VATC |
QS01AD02
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
||
|
WHO-ATC |
L01BC59
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
||
|
FDA ORPHAN DRUG |
564116
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
||
|
NDF-RT |
N0000175466
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
||
|
NDF-RT |
N0000175459
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
||
|
WHO-ATC |
S01AD02
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
||
|
NCI_THESAURUS |
C1557
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
200-722-8
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
PRIMARY | |||
|
RMW9V5RW38
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
PRIMARY | |||
|
D014271
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
PRIMARY | |||
|
10803
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
PRIMARY | RxNorm | ||
|
C448389
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
PRIMARY | |||
|
1686309
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
PRIMARY | |||
|
6256
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
PRIMARY | |||
|
75179
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
PRIMARY | |||
|
DB00432
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
PRIMARY | |||
|
TRIFLURIDINE
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
PRIMARY | |||
|
75520
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
PRIMARY | |||
|
DTXSID4046602
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
PRIMARY | |||
|
8697
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
PRIMARY | |||
|
C905
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
PRIMARY | |||
|
8126
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
PRIMARY | |||
|
70-00-8
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
PRIMARY | |||
|
m11125
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
PRIMARY | Merck Index | ||
|
100000076935
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
PRIMARY | |||
|
SUB11291MIG
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
PRIMARY | |||
|
RMW9V5RW38
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
PRIMARY | |||
|
4146
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
PRIMARY | |||
|
529182
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
PRIMARY | |||
|
2743
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
PRIMARY | |||
|
CHEMBL1129
Created by
admin on Sat Dec 16 16:28:09 UTC 2023 , Edited by admin on Sat Dec 16 16:28:09 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
EXCRETED UNCHANGED |
URINE
|
||
|
BINDER->LIGAND |
The in vitro protein binding in human plasma is greater than 96 % for trifluridine.
|
||
|
TARGET -> INHIBITOR |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE INACTIVE -> PARENT |
|
||
|
METABOLITE INACTIVE -> PARENT | |||
|
METABOLITE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||
Tmax | PHARMACOKINETIC |
|
SINGLE DOSE ADMINISTRATION |
|
||